Cargando…
The state of the art: immune-mediated mechanisms of monoclonal antibodies in cancer therapy
A number of antibody products have now become accepted as effective anti-cancer therapies. Despite being mainly designed to act by inhibiting functional tumour antigens, there is increasing evidence that Fc-mediated engagement of the immune system is an important contributor to the efficacy of sever...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788263/ https://www.ncbi.nlm.nih.gov/pubmed/19809433 http://dx.doi.org/10.1038/sj.bjc.6605349 |